+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VIVIMEDLAB

Vivimed Labs Share Price

 

 

Vivimed Labs live price: ₹5.79. It opened at ₹6 vs previous close ₹6; intraday high/low: ₹6/₹6. The 50 & 200 DMA stand at ₹6.34/₹8.30.

Vivimed Labs Performance

  • Today's Low
  • ₹6
  • Today's High
  • ₹6
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹29
  • Open Price₹6
  • Previous Close₹6
  • Volume42,203
  • 50 DMA₹6.34
  • 100 DMA₹7.00
  • 200 DMA₹8.30

Vivimed Labs Chart

Investment Returns

  • Over 1 Month -9.39%
  • Over 3 Month 0%
  • Over 6 Month -61.71%
  • Over 1 Year + 479%

Smart Investing Starts Here Start SIP with Vivimed Labs for Steady Growth!

Invest Now

Vivimed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 48
  • P/B Ratio
  • -0.7
  • Average True Range
  • 0.35
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.18
  • RSI
  • 40.02
  • MFI
  • 51.05

Latest Stock News Updates

Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y

Vivimed Labs Consolidated September 2023 Net Sales at Rs 33.64 crore, down 23.93% Y-o-Y

Vivimed Labs Standalone June 2023 Net Sales at Rs 33.00 crore, down 30.33% Y-o-Y

Vivimed Labs Financials

Vivimed Labs Technicals

EMA & SMA

Current Price
₹5.79
+ 0.06 (1.05%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹6.00
  • 50 Day
  • ₹6.30
  • 100 Day
  • ₹7.00
  • 200 Day
  • ₹8.30

Resistance and Support

5.83 Pivot Speed
  • R3 6.17
  • R2 6.07
  • R1 5.93
  • S1 5.69
  • S2 5.59
  • S3 5.45

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivimed Labs has an operating revenue of Rs. 83.60 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of -27% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivimed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results, Pref. issue & A.G.M.
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Vivimed Labs Shareholding Pattern

7.57%
0%
0%
1.64%
0%
68.75%
22.04%

Vivimed Labs FAQs

Vivimed Labs share price is ₹5 As on 04 July, 2026 | 18:42

The Market Cap of Vivimed Labs is ₹48 Cr As on 04 July, 2026 | 18:42

The P/E ratio of Vivimed Labs is -1.4 As on 04 July, 2026 | 18:42

The PB ratio of Vivimed Labs is -0.7 As on 04 July, 2026 | 18:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23